Chinese biotech firm Bao Pharma closes over $100m in Series B round

Chinese biotech firm Bao Pharma closes over $100m in Series B round

Laboratory equipment. Photo: Pixabay

29 August, 2022

antibody Bao Pharmaceuticals biotech Oriental Fortune Capital recombinant protein drugs

Printed by Unregistered user on Fri, 04 Jul 2025 11:56:23 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Sequoia China, Boyu lead $160m Series B round in biotech startup Frontera

Chinese insurers lead $150m rounds in biotech startup METiS

Read more from Greater China

China’s EV rivalry spills over to Thailand, tests local production goals

People Digest: responsAbility appoints CEO; Gaw Capital names data centre platform head